Americas vs Mongolia: Proportion of the target population who received a 3rd dose of
Americas
79.0%
in 2024
Mongolia
96.0%
in 2024
Americas rank
13th
Mongolia rank
15th
Proportion of the target population who received a 3rd dose of over time
- Americas
- Mongolia
How they compare
Mongolia currently reports 96.0% against 79.0% in Americas, a difference of 17.0%.
That makes Mongolia's figure about 1.2 times Americas's.
The two have swapped places 1 time across 8 shared years of data; in 2017 it was Americas ahead.
Americas ranks 13th and Mongolia ranks 15th of 31 groups.
Across the 2 decades both report, Americas averaged higher in 1 and Mongolia in 1.
Head to head by decade
| Decade | Americas | Mongolia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 81.3% | 29.3% | 52.0% | Americas |
| 2020s | 76.4% | 94.6% | 18.2% | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Americas or Mongolia?
- Mongolia, at 96.0% against 79.0% in Americas as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Americas and Mongolia?
- 17.0%, with Mongolia ahead.
- How many years of comparable data are there for Americas and Mongolia?
- 8 years are reported by both, from 2017 to 2024.
- How do Americas and Mongolia rank globally for proportion of the target population who received a 3rd dose of?
- Americas ranks 13th and Mongolia ranks 15th of 31 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.